ArticleJournal of radiation research2026
Development and clinical application of biological dosimetry technology: insights from the HICARE/IAEA 2025 international training course.
Article in Journal of radiation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The HICARE/IAEA 2025 International Training Course on Biological and Internal Dosimetry, held at Hiroshima University from 10 to 14 February 2025, convened 20 participants from nine countries- Brazil, Indonesia, Japan, Korea, the Philippines, Singapore, Thailand, the United States, and Vietnam-and was jointly organized by the Hiroshima International Council for Health Care of the Radiation-Exposed (HICARE) and the International Atomic Energy Agency (IAEA). With guidance from 13 expert lecturers, the course aimed to enhance global capacity in radiation dose assessment and clinical application of biodosimetry. The program, led by Prof. Satoshi Tashiro (HICARE) and Dr. Oleg Belyakov (IAEA), included lectures on cytogenetic assays, molecular biomarkers, and internal dosimetry using biokinetic modeling and bioassay data. Key themes emphasized the integration of biodosimetry into clinical decision-making, emergency preparedness, and occupational health monitoring. Discussions highlighted the expanding role of biodosimetry in complementing internal dose assessments for patients undergoing diagnostic imaging procedures-such as CT scans and nuclear medicine-as well as for individuals affected by radiological accidents. These sessions underscored the need for harmonized protocols, reliable dose reconstruction methods, and cross-institutional networks to support accurate and timely biodosimetric evaluations in both clinical and emergency settings. The workshop not only had advanced technical competencies but also positioned biodosimetry as a critical tool in global radiological protection strategies. Strong participant engagement and interest in future events reflected the course's impact on strengthening international cooperation and translating research into practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.